234 related articles for article (PubMed ID: 35874582)
1. Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations.
Jansen MH; Rondaan C; Legger G; Minden K; Uziel Y; Toplak N; Maritsi D; van den Berg M; Berbers G; Bruijning P; Egert Y; Normand C; Bijl M; Foster H; Kone-Paut I; Wouters C; Ravelli A; Elkayam O; Wulffraat NM; Heijstek MW
Front Pediatr; 2022; 10():910026. PubMed ID: 35874582
[TBL] [Abstract][Full Text] [Related]
2. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021.
Jansen MHA; Rondaan C; Legger GE; Minden K; Uziel Y; Toplak N; Maritsi D; van den Berg L; Berbers GAM; Bruijning P; Egert Y; Normand C; Bijl M; Foster HE; Koné-Paut I; Wouters C; Ravelli A; Elkayam O; Wulffraat NM; Heijstek MW
Ann Rheum Dis; 2023 Jan; 82(1):35-47. PubMed ID: 35725297
[TBL] [Abstract][Full Text] [Related]
3. Vaccinology in pediatric rheumatology: Past, present and future.
Bizjak M; Heshin-Bekenstein M; Jansen MHA; Ziv A; Angevare S; Uziel Y; Wulffraat NM; Toplak N;
Front Pediatr; 2022; 10():1098332. PubMed ID: 36704144
[TBL] [Abstract][Full Text] [Related]
4. Vaccination in paediatric patients with auto-immune rheumatic diseases: a systemic literature review for the European League against Rheumatism evidence-based recommendations.
Heijstek MW; Ott de Bruin LM; Borrow R; van der Klis F; Koné-Paut I; Fasth A; Minden K; Ravelli A; Abinun M; Pileggi G; Borte M; Bijl M; Wulffraat NM
Autoimmun Rev; 2011 Dec; 11(2):112-22. PubMed ID: 21896342
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.
Rondaan C; Furer V; Heijstek MW; Agmon-Levin N; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; Ladefoged de Thurah A; Landewé R; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; van Assen S; Elkayam O
RMD Open; 2019; 5(2):e001035. PubMed ID: 31565247
[TBL] [Abstract][Full Text] [Related]
6. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.
Furer V; Rondaan C; Heijstek MW; Agmon-Levin N; van Assen S; Bijl M; Breedveld FC; D'Amelio R; Dougados M; Kapetanovic MC; van Laar JM; de Thurah A; Landewé RB; Molto A; Müller-Ladner U; Schreiber K; Smolar L; Walker J; Warnatz K; Wulffraat NM; Elkayam O
Ann Rheum Dis; 2020 Jan; 79(1):39-52. PubMed ID: 31413005
[TBL] [Abstract][Full Text] [Related]
7. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
[TBL] [Abstract][Full Text] [Related]
8. Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: Multicenter, retrospective data collection.
Uziel Y; Moshe V; Onozo B; Kulcsár A; Tróbert-Sipos D; Akikusa JD; Salviato Pileggi G; Maritsi D; Kasapcopur O; Rodrigues M; Smerla R; Rigante D; Makay B; Atsali E; Wulffraat N; Toplak N;
Vaccine; 2020 Feb; 38(9):2198-2201. PubMed ID: 31987692
[TBL] [Abstract][Full Text] [Related]
9. Vaccination of Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases - EULAR/PRES Updated Recommendations, 2021.
Sharanya P; Kota VR
Indian Pediatr; 2023 Nov; 60(11):947-950. PubMed ID: 37950473
[TBL] [Abstract][Full Text] [Related]
10. Vaccinations in paediatric rheumatology: an update on current developments.
Groot N; Heijstek MW; Wulffraat NM
Curr Rheumatol Rep; 2015 Jul; 17(7):46. PubMed ID: 26025339
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Vaccination in Pediatric Patients with Systemic Inflammatory Rheumatic Diseases: a systematic review of the literature.
Sousa S; Duarte AC; Cordeiro I; Ferreira J; Gonçalves MJ; Meirinhos T; Rocha TM; Romão VC; Santos MJ
Acta Reumatol Port; 2017; 42(1):8-16. PubMed ID: 28133957
[TBL] [Abstract][Full Text] [Related]
12. Vaccines for measles, mumps, rubella, and varicella in children.
Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for measles, mumps, rubella, and varicella in children.
Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004407. PubMed ID: 34806766
[TBL] [Abstract][Full Text] [Related]
14. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.
van Assen S; Elkayam O; Agmon-Levin N; Cervera R; Doran MF; Dougados M; Emery P; Geborek P; Ioannidis JP; Jayne DR; Kallenberg CG; Müller-Ladner U; Shoenfeld Y; Stojanovich L; Valesini G; Wulffraat NM; Bijl M
Autoimmun Rev; 2011 Apr; 10(6):341-52. PubMed ID: 21182987
[TBL] [Abstract][Full Text] [Related]
15. Long-term immunoprotection after live attenuated measles-mumps-rubella booster vaccination in children with juvenile idiopathic arthritis.
Hamad Saied M; van Straalen JW; de Roock S; de Joode-Smink GCJ; Verduyn Lunel FM; Swart JF; Wulffraat NM; Jansen MHA
Vaccine; 2023 Aug; 41(37):5477-5482. PubMed ID: 37516575
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for Vaccination in Adult Patients with Systemic Inflammatory Rheumatic Diseases from the Portuguese Society of Rheumatology.
Cordeiro I; Duarte AC; Ferreira JF; Gonçalves MJ; Meirinhos T; Rocha TM; Romão VC; Sousa S; Guedes M; Conde M; Abreu C; Aleixo MJ; Santos MJ
Acta Reumatol Port; 2016; 41(2):112-30. PubMed ID: 27606471
[TBL] [Abstract][Full Text] [Related]
17. Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial.
Heijstek MW; Kamphuis S; Armbrust W; Swart J; Gorter S; de Vries LD; Smits GP; van Gageldonk PG; Berbers GA; Wulffraat NM
JAMA; 2013 Jun; 309(23):2449-56. PubMed ID: 23780457
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children.
Namazova-Baranova L; Habib MA; Povey M; Efendieva K; Fedorova O; Fedoseenko M; Ivleva T; Kovshirina Y; Levina J; Lyamin A; Ogorodova L; Reshetko O; Romanenko V; Ryzhenkova I; Sidorenko I; Yakovlev Y; Zhestkov A; Tatochenko V; Scherbakov M; Shpeer EL; Casabona G;
Hum Vaccin Immunother; 2022 Jan; 18(1):1959148. PubMed ID: 34435933
[TBL] [Abstract][Full Text] [Related]
19. Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries.
Prymula R; Povey M; Brzostek J; Cabrnochova H; Chlibek R; Czajka H; Leviniene G; Man S; Neamtu M; Pazdiora P; Plesca D; Ruzkova R; Stefkovicova M; Usonis V; Verdanova D; Wysocki J; Casabona G; Habib MA
Vaccine; 2021 May; 39(19):2643-2651. PubMed ID: 33858718
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of vaccination in children with paediatric rheumatic diseases: a scoping review.
Cunninghame J; Wen S; Dufficy M; Ullman A; Takashima M; Cann M; Doyle R
Ther Adv Vaccines Immunother; 2023; 11():25151355231167116. PubMed ID: 37124959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
